Evidence map›Paper›PMID 42538285›Full record

ArticleTobacco control2026

Pilot randomised controlled trial of an e-cigarette and tobacco use intervention for hospitalised youth.

Abbey R Masonbrink, Shelbie Wooten, Hung-Wen Yeh, Stephani Stancil, Melissa K Miller, Karen Wilson, Tamara D Simon, Adam Leventhal, Delwyn Catley

Registry-linked trialAbstract read
In one paragraph

Article in Tobacco control, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05936099 (Development and Implementation of a Tobacco and ENDS Use Intervention for Adolescents and Young Adults in the Pediatric Hospital), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05936099 nacompletednot on this map

Development and Implementation of a Tobacco and ENDS Use Intervention for Adolescents and Young Adults in the Pediatric Hospital

TypeinterventionalSponsorChildren's Mercy Hospital Kansas CityRan2023 to 2025Enrolled144ConditionsVaping, SmokingArmsE-cigarette & Tobacco Use Treatment Intervention
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Abbey R MasonbrinkKeck School of Medicine, University of Southern California, Los Angeles, California, USA amasonbrink@chla.usc.edu.ORCID http://orcid.org/0000-0001-5679-8320
Shelbie WootenPediatrics, Children's Mercy Kansas City, Kansas City, Missouri, USA.ORCID http://orcid.org/0009-0001-2503-2266
Hung-Wen YehPediatrics, Children's Mercy Kansas City, Kansas City, Missouri, USA.ORCID http://orcid.org/0000-0002-9904-3275
Stephani StancilPediatrics, Children's Mercy Kansas City, Kansas City, Missouri, USA.ORCID http://orcid.org/0000-0001-7308-3132
Melissa K MillerDepartment of Pediatrics, University of Missouri-Kansas City, Kansas City, Missouri, USA.ORCID http://orcid.org/0000-0002-8672-4944
Karen WilsonUniversity of Rochester School of Medicine and Dentistry, Rochester, New York, USA.ORCID http://orcid.org/0000-0002-2703-7001
Tamara D SimonKeck School of Medicine, University of Southern California, Los Angeles, California, USA.ORCID http://orcid.org/0000-0003-4734-7020
Adam LeventhalPreventive Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.ORCID http://orcid.org/0000-0002-1217-525X
Delwyn CatleySan Diego State University, San Diego, California, USA.ORCID http://orcid.org/0000-0002-7270-8732

Funding

Development and Implementation of a Tobacco and ENDS Use Intervention for Adolescents and Young Adults in the Pediatric HospitalK23DA055736 · NIDA · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI Abbey Masonbrink · 2022 to 2026
$961k
NIDA NIH HHS K23 DA055736
6 · The paper itself

Abstract

introductionWe sought to evaluate preliminary efficacy and implementation outcomes of an e-cigarette and tobacco cessation intervention for hospitalised youth in the USA.

methodsWe conducted a pilot randomised controlled trial at a paediatric hospital with 3-month follow-up from August 2023 to December 2024. Hospitalised youth (14-21 years) with self-reported past 30-day e-cigarette use were eligible. Exclusions included severe medical/psychiatric illness, cognitive impairment and inability to communicate in English. Intervention entailed health education, motivational interviewing counselling, quit planning, nicotine replacement therapy (NRT) and phone booster sessions. Control entailed brief advice and quit programme referral. The primary outcome was self-reported past 30-day e-cigarette abstinence at 3 months with biochemical confirmation with intention-to-treat (ITT) sensitivity analysis. Implementation outcomes included acceptability, feasibility and fidelity.

resultsIn 144 hospitalised youth enrolled, the mean age was 16.2 years (SD: 1.3) and 62% were female. At 3 months there was no difference in past 30-day e-cigarette abstinence between arms (intervention 43% vs control 42%; p=0.91). In ITT analysis we found the OR of abstinence was OR 0.77 (95% CI 0.27 to 2.19, p=0.62) in the intervention versus control. Mean fidelity score was 43 (SD: 3; out of 50). All intervention participants (n=96) completed the initial in-person intervention, 49% made a quit plan, of those 23% were prescribed NRT. Most (89%) were somewhat/very satisfied with the intervention.

conclusionsOur study is among the first to demonstrate promising implementation but not efficacy of an e-cigarette cessation intervention in hospitalised youth. Future work is needed to enhance intervention efficacy in this population. TRIAL REGISTRATION NUMBER: NCT05936099.

Indexed as

AddictionCessationNicotinePrimary Health CarePriority/special populations

Identifiers

PMID42538285
PMCPMC13637973

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.